US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
EP0183901B1
(de)
*
|
1984-11-27 |
1992-07-08 |
BEHRINGWERKE Aktiengesellschaft |
Bifunktionelle Haptene, Verfahren zu ihrer Herstellung und ihre Verwendung
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
US5576195A
(en)
|
1985-11-01 |
1996-11-19 |
Xoma Corporation |
Vectors with pectate lyase signal sequence
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
ES2184734T3
(es)
|
1987-04-27 |
2003-04-16 |
Inverness Medical Switzerland |
Dispositivo de prueba analitica para realizar ensayos de union especifica.
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
JPH02111798A
(ja)
*
|
1988-10-20 |
1990-04-24 |
Fuji Photo Film Co Ltd |
蛋白質修飾物
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
DE69232002T2
(de)
*
|
1991-06-07 |
2002-06-06 |
Johnson & Johnson Clin Diag |
Immunoassays unter Verwendung von markierten Hapten-Analogen
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
AU668159B2
(en)
|
1992-05-29 |
1996-04-26 |
Lilly Industries Limited |
Pharmaceutical compounds
|
ATE176329T1
(de)
|
1992-06-26 |
1999-02-15 |
Johnson & Johnson Clin Diag |
Immunotests unter verwendung von markierten thyronin-analogen
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
CZ293764B6
(cs)
|
1993-11-19 |
2004-07-14 |
Janssen Pharmaceutica N. V. |
Farmaceutický prostředek s dostatečným a dlouhodobým uvolňováním léčiva, biodegradovatelné a biokompatibilní mikročástice, způsob jejich výroby a použití
|
CA2192467C
(en)
|
1994-06-10 |
2009-03-31 |
Alireza Rezaie |
Calcium binding recombinant antibody against protein c
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
US6139800A
(en)
|
1997-06-23 |
2000-10-31 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
JPH1151935A
(ja)
*
|
1997-08-06 |
1999-02-26 |
Aisin Seiki Co Ltd |
複数種類のターゲット分子の同時検出方法
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
RU2181297C2
(ru)
*
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
US7163681B2
(en)
*
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
US7288390B2
(en)
*
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
DE60335428D1
(de)
|
2002-01-31 |
2011-02-03 |
Randox Lab Ltd |
Immunogene, Antikörper und Konjugate für Ketamin und dessen Metaboliten
|
WO2003072736A2
(en)
|
2002-02-21 |
2003-09-04 |
Duke University |
Reagents and treatment methods for autoimmune diseases
|
EP1490090A4
(en)
|
2002-02-22 |
2006-09-20 |
New River Pharmaceuticals Inc |
SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
|
JP2005533009A
(ja)
|
2002-03-28 |
2005-11-04 |
イーライ・リリー・アンド・カンパニー |
ピペラジン置換されたアリールベンゾジアゼピン類およびそのドーパミン受容体アンタゴニストとしての精神病性障害の処置のための使用
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
WO2004011031A1
(en)
|
2002-07-29 |
2004-02-05 |
Potomac, Pharma, Llc. |
Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
|
AU2003264915A1
(en)
|
2002-08-05 |
2004-02-25 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines
|
US20040193446A1
(en)
|
2003-03-27 |
2004-09-30 |
Mayer Steven Lloyd |
System and method for managing a patient treatment program including a prescribed drug regimen
|
US7271252B2
(en)
*
|
2003-04-22 |
2007-09-18 |
Roche Diagnostics Operations, Inc. |
Reagents for detecting efavirenz
|
JP5416338B2
(ja)
|
2003-05-09 |
2014-02-12 |
デューク ユニバーシティ |
Cd20特異的抗体およびその使用方法
|
MXPA06001938A
(es)
*
|
2003-08-18 |
2006-05-17 |
Lundbeck & Co As H |
Trans-1-(6-cloro-3-fenilindan-1-il)-3,3-dimetilpiperazina.
|
CA2538745A1
(en)
|
2003-09-23 |
2005-03-31 |
Fermion Oy |
Preparation of quetiapine
|
CN100549004C
(zh)
|
2003-10-01 |
2009-10-14 |
阿得罗公司 |
螺环杂环衍生物及其应用方法
|
ZA200602347B
(en)
|
2003-10-23 |
2007-09-26 |
Otsuka Pharma Co Ltd |
Controlled release sterile injectable aripiprazole formulation and method
|
GB0328892D0
(en)
*
|
2003-12-12 |
2004-01-14 |
Inverness Medical Switzerland |
Positive signal assay for analytes
|
AU2004298660B2
(en)
*
|
2003-12-12 |
2010-04-22 |
Abbott Rapid Diagnostics International Unlimited Company |
Assay
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
JP2005292087A
(ja)
*
|
2004-04-05 |
2005-10-20 |
Shionogi & Co Ltd |
5’−デオキシ−5’−メチルチオアデノシンに対する抗体
|
EP1748070A4
(en)
|
2004-04-26 |
2007-07-18 |
Takami Matsuyama |
THERAPEUTIC WITH MONOCLONAL ANTIBODY AGAINST FOLAT RECEPTOR BETA (FR-BETA)
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
WO2006114384A1
(en)
|
2005-04-25 |
2006-11-02 |
Janssen Pharmaceutica N.V. |
Preparation of aseptic 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4h-pyridio[1,2-a]pyrimidin-4-one palmitate ester
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
SE0501418L
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
WO2008047925A1
(fr)
|
2006-10-20 |
2008-04-24 |
Forerunner Pharma Research Co., Ltd. |
Composition pharmaceutique comprenant un anticorps anti-hb-egf comme ingrédient actif
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
JP2010507648A
(ja)
*
|
2006-10-25 |
2010-03-11 |
ラモット アット テル−アビブ ユニバーシティー リミテッド |
グルタミン酸nmda活性を有する新規向精神薬
|
US20080138842A1
(en)
|
2006-12-11 |
2008-06-12 |
Hans Boehringer |
Indirect lateral flow sandwich assay
|
CA2672581A1
(en)
|
2006-12-14 |
2008-06-19 |
Forerunner Pharma Research Co., Ltd. |
Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
|
JP5450092B2
(ja)
|
2006-12-29 |
2014-03-26 |
アボット・ラボラトリーズ |
全血中の分子または薬物の検出のための診断検査
|
CN101600716A
(zh)
|
2007-01-08 |
2009-12-09 |
阿特维斯集团公司 |
用于制备9-羟基-3-(2-氯乙基)-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮盐酸盐的改进方法
|
CN101245065B
(zh)
|
2007-02-14 |
2010-05-19 |
江苏恩华药业股份有限公司 |
制备苯并异噁唑衍生物的方法及其中间体
|
JP2010540920A
(ja)
|
2007-09-27 |
2010-12-24 |
ノバルティス アーゲー |
薬物モニタリングアッセイ
|
US8133743B2
(en)
|
2007-10-19 |
2012-03-13 |
Roche Diagnostics Operations, Inc. |
Phenobarbital derivatives useful in immunoassay
|
WO2009134855A1
(en)
*
|
2008-04-29 |
2009-11-05 |
Psychemedics Corporation |
Solid phase multi-analyte assay
|
WO2010009987A2
(en)
|
2008-07-21 |
2010-01-28 |
Probiodrug Ag |
Diagnostic antibody assay
|
JP2011529923A
(ja)
*
|
2008-08-06 |
2011-12-15 |
ゴスフォース センター(ホールディングス)プロプライエタリー リミテッド |
精神障害(psychiatricdisorder)を治療するための組成物および方法
|
US20100069356A1
(en)
|
2008-09-17 |
2010-03-18 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
MX2011003598A
(es)
|
2008-10-14 |
2011-04-27 |
Astrazeneca Ab |
Compuestos heteroaromaticos espirociclicos, fusionados, para el tratamiento de infecciones bacterianas.
|
EP2347015A4
(en)
*
|
2008-10-29 |
2012-12-19 |
Janssen Pharmaceutica Nv |
METHOD FOR THE TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA BASED ON POLYMORPHISMS IN THE ERBB4 GEN
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
NZ594071A
(en)
*
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
EP3138854B1
(en)
|
2009-03-10 |
2022-01-26 |
Baylor Research Institute |
Antibodies against cd40
|
JP5732453B2
(ja)
|
2009-06-25 |
2015-06-10 |
アルカーメス ファーマ アイルランド リミテッド |
Nh酸性化合物のプロドラッグ
|
ES2833035T3
(es)
|
2009-07-31 |
2021-06-14 |
Ascendis Pharma As |
Hidrogeles biodegradables insolubles en agua a base de polietilenglicol
|
WO2011021381A1
(ja)
|
2009-08-17 |
2011-02-24 |
株式会社未来創薬研究所 |
抗hb-egf抗体を有効成分として含む医薬組成物
|
US8076097B2
(en)
|
2009-08-19 |
2011-12-13 |
Saladax Biomedical Inc. |
Imatinib immunoassay
|
US20130053405A1
(en)
|
2009-10-06 |
2013-02-28 |
Ulrich Hersel |
Carrier linked paliperidone prodrugs
|
EP2343296A1
(en)
|
2009-12-01 |
2011-07-13 |
Chemo Ibérica, S.A. |
A process for the purification of paliperidone
|
AU2010336981B2
(en)
|
2009-12-31 |
2014-04-10 |
Kempharm, Inc. |
Amino acid conjugates of quetiapine, process for making and using the same
|
EP2544536B1
(en)
|
2010-03-11 |
2018-12-12 |
Kempharm, Inc. |
Fatty acid conjugates of quetiapine, process for making and using the same
|
US8114621B2
(en)
|
2010-03-12 |
2012-02-14 |
Saladax Biomedical Inc. |
Lenalidomide and thalidomide immunoassays
|
US8088594B2
(en)
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
WO2011159537A2
(en)
*
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
ES2691671T3
(es)
|
2010-06-24 |
2018-11-28 |
Alkermes Pharma Ireland Limited |
Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
|
US9156822B2
(en)
|
2010-07-02 |
2015-10-13 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine D2 receptors
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
CN102276624B
(zh)
|
2011-06-17 |
2013-10-16 |
大连理工大学 |
一种奥氮平有关物质及其制备方法和高效液相色谱分析方法
|
CN102276592B
(zh)
|
2011-06-17 |
2013-10-16 |
大连理工大学 |
一种奥氮平有关物质及其制备方法、分析方法
|
CA2843875C
(en)
|
2011-08-12 |
2020-01-07 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
AU2012296950B2
(en)
|
2011-08-12 |
2016-09-22 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
AU2012351747B2
(en)
|
2011-12-15 |
2016-05-12 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
WO2014028800A1
(en)
|
2012-08-16 |
2014-02-20 |
Janssen Pharmaceutica Nv |
Substituted pyrazoles as n-type calcium channel blockers
|
WO2014031587A1
(en)
|
2012-08-21 |
2014-02-27 |
Janssen Pharmaceutica Nv |
Haptens of olanzipine
|
JP6389176B2
(ja)
|
2012-08-21 |
2018-09-12 |
ヤンセン ファーマシューティカ エヌ.ベー. |
アリピプラゾールハプテンに対する抗体及びその使用
|
US9304126B2
(en)
|
2012-08-21 |
2016-04-05 |
Janssen Pharmaceutica Nv |
Haptens of quetiapine
|
TR201816416T4
(tr)
|
2012-08-21 |
2018-11-21 |
Janssen Pharmaceutica Nv |
Risperidona yönelik antikorlar ve bunların kullanımı.
|
JP6131500B2
(ja)
*
|
2012-08-21 |
2017-05-24 |
ヤンセン ファーマシューティカ エヌ.ベー. |
リスペリドン及びパリペリドンのハプテン
|
JP2015529199A
(ja)
*
|
2012-08-21 |
2015-10-05 |
オルソ−クリニカル ダイアグノスティクス,インコーポレイティド |
パリペリドンハプテンに対する抗体及びその使用
|
AU2013305907B2
(en)
|
2012-08-21 |
2018-01-18 |
Saladax Biomedical Inc. |
Antibodies to quetiapine and use thereof
|
US9465041B2
(en)
*
|
2012-08-21 |
2016-10-11 |
Janssen Pharmaceutica Nv |
Antibodies to paliperidone and use thereof
|
CA2882596C
(en)
|
2012-08-21 |
2019-05-14 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to olanzapine and use thereof
|
CN108484496B
(zh)
|
2012-08-21 |
2022-03-22 |
詹森药业有限公司 |
阿立哌唑半抗原及其在免疫测定中的应用
|
TR201910347T4
(tr)
|
2012-08-21 |
2019-07-22 |
Janssen Pharmaceutica Nv |
Olanzapin haptenlerine yönelik antikorlar ve bunların kullanımı.
|
JP6374387B2
(ja)
|
2012-08-21 |
2018-08-15 |
ヤンセン ファーマシューティカ エヌ.ベー. |
リスペリドンハプテンへの抗体及びその使用
|
WO2014031595A1
(en)
*
|
2012-08-21 |
2014-02-27 |
Janssen Pharmaceutica Nv |
Haptens of paliperidone
|
AU2013305904B2
(en)
|
2012-08-21 |
2017-08-17 |
Saladax Biomedical Inc. |
Antibodies to quetiapine haptens and use thereof
|
ES2666000T3
(es)
|
2012-08-21 |
2018-04-30 |
Janssen Pharmaceutica, N.V. |
Anticuerpos para aripiprazol y uso de los mismos
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
AU2016372069A1
(en)
|
2015-12-17 |
2018-06-07 |
Saladax Biomedical Inc. |
Antibodies to risperidone and use thereof
|